← Back to Analyst Consensus 
WGS Buy
GeneDx Holdings Corp.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 1, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 4, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 4, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 29, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 23, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| May 5, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 5, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 5, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 5, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Apr 20, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 30, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Feb 24, 2026 | Piper Sandler | maintain | Overweight → Overweight | $130 | 54% |
| Feb 24, 2026 | BTIG | maintain | Buy → Buy | $170 | 52% |
| Feb 9, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | $155 | 54% |
| Dec 22, 2025 | Canaccord Genuity | maintain | Buy → Buy | $170 | 48% |
| Dec 15, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $155 | 54% |
| Dec 12, 2025 | BTIG | maintain | Buy → Buy | $200 | 52% |
| Nov 4, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $140 | 54% |
| Oct 29, 2025 | Canaccord Genuity | maintain | Buy → Buy | $160 | 48% |
| Oct 29, 2025 | Guggenheim | maintain | Buy → Buy | $170 | 52% |
| Oct 29, 2025 | BTIG | maintain | Buy → Buy | $165 | 52% |
| Oct 22, 2025 | BTIG | maintain | Buy → Buy | $140 | 52% |
| Oct 20, 2025 | Canaccord Genuity | initiate | — → Buy | $155 | 48% |
| Sep 11, 2025 | Piper Sandler | maintain | Overweight → Overweight | $140 | 54% |
| Aug 4, 2025 | Piper Sandler | maintain | Overweight → Overweight | $120 | 54% |
| Jul 30, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $95 | 54% |
| Jul 9, 2025 | Piper Sandler | initiate | — → Overweight | $110 | 54% |
| Jun 30, 2025 | Guggenheim | maintain | Buy → Buy | $115 | 52% |
| May 9, 2025 | Jefferies | upgrade | Hold → Buy | $80 | 52% |
| May 1, 2025 | TD Securities | maintain | Buy → Buy | $110 | 54% |
| May 1, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $78 | 54% |
| Feb 19, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $80 | 54% |
| Jan 7, 2025 | TD Cowen | maintain | Buy → Buy | $118 | 54% |
| Oct 30, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $70 | 54% |
| Oct 30, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $75 | 54% |
| Oct 30, 2024 | Craig-Hallum | maintain | Buy → Buy | $95 | 54% |
| Oct 24, 2024 | Craig-Hallum | maintain | Buy → Buy | $70 | 54% |
| Oct 16, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $54 | 54% |
| Aug 27, 2024 | Wells Fargo | initiate | — → Equal-Weight | $34 | 54% |
| Jul 31, 2024 | TD Cowen | maintain | Buy → Buy | $50 | 54% |
| Jul 31, 2024 | BTIG | maintain | Buy → Buy | $45 | 52% |
| Jul 31, 2024 | Craig-Hallum | maintain | Buy → Buy | $46 | 54% |
| Jul 31, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $32 | 54% |
| Jul 17, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $28 | 54% |
| Jul 10, 2024 | Craig-Hallum | initiate | — → Buy | $43 | 54% |
| Jun 26, 2024 | BTIG | maintain | Buy → Buy | $35 | 52% |
| Apr 30, 2024 | TD Cowen | maintain | Buy → Buy | $24 | 54% |
| Apr 30, 2024 | BTIG | maintain | Buy → Buy | $19 | 52% |
| Apr 22, 2024 | BTIG | maintain | Buy → Buy | $15 | 52% |
| Apr 15, 2024 | Goldman Sachs | maintain | Neutral → Neutral | $11 | 54% |
Price Target Trend
Jul 6, 2026 Latest: $93.5 Oct 25, 2026
EPS Estimates
0y $0.13
Lo: $0.02 Hi: $0.32
7 analysts +1q $0.32
Lo: $0.21 Hi: $0.50
7 analysts 0q $0.07
Lo: $0.07 Hi: $0.08
7 analysts +1y $1.20
Lo: $0.44 Hi: $2.00
7 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days